Dejan Milasinovic (@milasind18) 's Twitter Profile
Dejan Milasinovic

@milasind18

ID: 985471367884820480

calendar_today15-04-2018 10:54:18

243 Tweet

789 Followers

52 Following

A.Nazmi Calik (@anazmicalik) 's Twitter Profile Photo

🟣#EAPCI-PCR Fellows Course 2025🟣 What a fantastic way to kick off #EuroPCR 2025!!! 🗓️19 May - Paris, Palais des congrès 💟STEMI 💟Multivessel disease 💟Presentation & Communication skills 💟Left main PCI 💟Calcified lesion PCI Chiara De Biase Gabor G Toth Dejan Milasinovic Salvatore Brugaletta

🟣#EAPCI-PCR Fellows Course 2025🟣

What a fantastic way to kick off #EuroPCR 2025!!!

🗓️19 May - Paris, Palais des congrès

💟STEMI 
💟Multivessel disease
💟Presentation & Communication skills
💟Left main PCI
💟Calcified lesion PCI

<a href="/kiadeb87/">Chiara De Biase</a> <a href="/gabor_gt/">Gabor G Toth</a> <a href="/MilasinD18/">Dejan Milasinovic</a> <a href="/sbrugaletta/">Salvatore Brugaletta</a>
DrThomasCuisset (@cuissetdr) 's Twitter Profile Photo

I am really looking forward to a new type of session at #EuroPCR this year that will aim to bridge the gap between research and real-world practice with sessions that put clinical cases at the center. pcronline.com/Courses/EuroPC… Nieves Gonzalo nicolas dumonteil PCRonline 🫀

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

The special issue of EuroIntervention, which will be distributed in print next week during EuroPCR (but is already available online for those who wish to read it), is hypertrophic—and at times I even wonder if we may have overdone it (but it’s the 20th anniversary year—so it’s

The special issue of EuroIntervention, which will be distributed in print next week during EuroPCR (but is already available online for those who wish to read it), is hypertrophic—and at times I even wonder if we may have overdone it (but it’s the 20th anniversary year—so it’s
PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

View the full list of simultaneous publications at #EuroPCR 🇫🇷 2025 here ➡️ pcronline.com/Courses/EuroPC… EAPCIPresident EuroIntervention #science #innovation #interventionalcardiology

View the full list of simultaneous publications at #EuroPCR 🇫🇷 2025 here ➡️ pcronline.com/Courses/EuroPC…

<a href="/EAPCIPresident/">EAPCIPresident</a> <a href="/EuroInterventio/">EuroIntervention</a>  #science #innovation #interventionalcardiology
MyJSCAI (@myjscai) 's Twitter Profile Photo

🆕📖Why is #intracoronary #imaging underutilized despite strong evidence? New white paper at #EuroPCR explores key barriers & proposes actions for wider integration💡 ➡️doi.org/10.1016/j.jsca… Javier Escaned Marco Lombardi Mamas A. Mamas Nieves Gonzalo Matthias Götberg Salvatore Brugaletta Dejan Milasinovic

🆕📖Why is #intracoronary #imaging underutilized despite strong evidence? New white paper at #EuroPCR explores key barriers &amp; proposes actions for wider integration💡

➡️doi.org/10.1016/j.jsca…

<a href="/JEscaned/">Javier Escaned</a> <a href="/MarLombard1/">Marco Lombardi</a> <a href="/mmamas1973/">Mamas A. Mamas</a> <a href="/NievesGonzalo1/">Nieves Gonzalo</a> <a href="/MGtberg/">Matthias Götberg</a> <a href="/sbrugaletta/">Salvatore Brugaletta</a> <a href="/MilasinD18/">Dejan Milasinovic</a>
Nieves Gonzalo (@nievesgonzalo1) 's Twitter Profile Photo

🔥#EuroPCR 2025 Major Late-Breaking Trials results: Angiography versus physiology-guided PCI in patients undergoing TAVI FAITAVI is the first study comparing FFR-guided PCI with angiography-guided PCI in patients with intermediate CAD and severe symptomatic AS undergoing TAVI,

🔥#EuroPCR 2025 Major Late-Breaking Trials results:   Angiography versus physiology-guided PCI in patients undergoing TAVI

FAITAVI is the first study comparing FFR-guided PCI with angiography-guided PCI in patients with intermediate CAD and severe symptomatic AS undergoing TAVI,
DrThomasCuisset (@cuissetdr) 's Twitter Profile Photo

#EuroPCR 2025 Major Late-Breaking Trials – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose Results of the 4D-ACS randomised trial show that, at 12-months, NACE occurred in 4.9% of the 1-month #DAPT group and 8.8% of the 12-month DAPT

#EuroPCR 2025 Major Late-Breaking Trials – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose

Results of the 4D-ACS randomised trial show that, at 12-months, NACE occurred in 4.9% of the 1-month #DAPT group and 8.8% of the 12-month DAPT
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

I could not have imagined a better way to mark this 20th anniversary than by sharing it with the many individuals who read and contribute to EuroIntervention. This milestone is not only ours—as editors, editorial team, and publishers—but belongs to the entire interventional

I could not have imagined a better way to mark this 20th anniversary than by sharing it with the many individuals who read and contribute to EuroIntervention. This milestone is not only ours—as editors, editorial team, and publishers—but belongs to the entire interventional
Nieves Gonzalo (@nievesgonzalo1) 's Twitter Profile Photo

Dear colleagues, dear #EuroPCR attendees, Thank you for taking the time out of your busy schedules to attend the 2025 edition. Your presence and your shared passion for improving patient care made the Course truly special. I'm very grateful to all presenters and faculty who

Dear colleagues, dear #EuroPCR attendees,

Thank you for taking the time out of your busy schedules to attend the 2025 edition. Your presence and your shared passion for improving patient care made the Course truly special.

I'm very grateful to all presenters and faculty who
Javier Escaned (@jescaned) 's Twitter Profile Photo

🔄Introducing RENEW PCI 2025. ✅RENEW is an acronym whose first letter, R, stands for Rethink. ✅We believe that rethinking our PCI practice is key to identifying entrenched behaviours, considering areas for improvement, and paving the way for Personalised Interventional Care.

🔄Introducing RENEW PCI 2025.
✅RENEW is an acronym whose first letter, R, stands for Rethink.
✅We believe that rethinking our PCI practice is key to identifying entrenched behaviours, considering areas for improvement, and paving the way for Personalised Interventional Care.
Salvatore Brugaletta (@sbrugaletta) 's Twitter Profile Photo

Happy to share the final step of this project started a year ago.the aim was to have something ready to consult in the cath lab for fellows and for early practitioners for the most common procedures you may face. From vascular access to bifurcation, CTO, TAVI or LAAC. I hope this

Happy to share the final step of this project started a year ago.the aim was to have something ready to consult in the cath lab for fellows and for early practitioners for the most common procedures you may face. From vascular access to bifurcation, CTO, TAVI or LAAC. I hope this
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

Episode 2 of Turning Point is here! Host Aaysha Cader speaks with Rasha Al-Lamee about her path from clinician to pioneering researcher. From early grant struggles to leading the ORBITA trial, discover how resilience, courage & teamwork shaped her career.

PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

🫀Valvular interventions: are we entering the new age? 🤝Join Dejan Milasinovic and Nicole Karam, MD, PhD, FESC for an exclusive Heart to Heart Conversation! 📅Monday 29 September, 4:00pm (UTC+2) 🔗 Watch live and join the conversation: pcronline.com/Webinars/PCR-W…

🫀Valvular interventions: are we entering the new age?
🤝Join <a href="/MilasinD18/">Dejan Milasinovic</a> and <a href="/nickaram/">Nicole Karam, MD, PhD, FESC</a> for an exclusive Heart to Heart Conversation!
📅Monday 29 September, 4:00pm (UTC+2)
🔗 Watch live and join the conversation: pcronline.com/Webinars/PCR-W…